Book talks how Dawood’s mentor made him a mafia boss

Agencies
April 1, 2019

New Delhi, Apr 1: Had it not been for Khalid Khan Bachcha, Dawood Ibrahim would not have been Dawood; he would have perished in obscurity long ago, killed either by his rivals or the police, says a new book.

"Dawood's Mentor: The Man Who Made India's Biggest Don" chronicles how Dawood meets Khalid and they eventually forge an unlikely friendship. Together they defeat and neutralise every mafia gang in Mumbai. Khalid lays the foundation for the D-Gang as Dawood goes on to establish a crime syndicate and becomes India's most wanted criminal.

According to author Hussain Zaidi, Khalid had left an indelible impression in Dawood's mind.

"Khalid had taught him the felicity to survive against the heaviest odds. Khalid’s lessons never went waste with Dawood," he writes.

Tired of being bullied, a scrawny, impoverished Dawood was looking for a saviour when Khalid taught him the ropes of handling a bunch of hooligans.

Dawood got a mentor who eventually transformed him into a cunning mafia boss.

Khalid once saved Dawood’s life and took a bullet for him. Khalid's presence of mind, courage and agility had saved Dawood from certain death.

"Dawood owed his life and power to this man. The story of this Pathan - Khalid Khan, alias Khalid Pehelwan, alias KP - was untold yet," says Zaidi.

"In my limited understanding of the Mumbai mafia, I had always felt that Khalid was an unlikely gangster and did not belong to the oligarchy of Dawood's gang. Yet, he had become integral to the growing clout, notoriety and power of the gang," he writes in the book published by Penguin Random House.

"I also wanted to know the motivations that drove a pehelwan (wrestler) into the mafia’s waiting arms. And most of all I was interested in knowing how Khalid Pehelwan survived Dawood’s ire. Imagine disassociating with Dawood and living to tell the tale. I wanted to know why Dawood respected his mentor," he says.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 2,2020

New Delhi, Jun 2: India on Tuesday reported 8,171 more COVID-19 cases and 204 deaths in the last 24 hours as the country's virus count inches closer to two lakh, according to the Union Ministry of Health and Family Welfare.

The total number of cases in the country now stands at 1,98,706 including 97,581 active cases, 95,527 cured/discharged/migrated and 5,598 deaths.

Cases in Maharashtra have crossed 70,000 including over 30,000 recovered while Tamil Nadu's COVID-19 tally jumped to 23,495.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 6,2020

New Delhi, Apr 6: With an increase of 490 cases in the last 12 hours, the total number of COVID-19 positive cases in India climbed to 4067, said Ministry of Health and Family Welfare on Monday.

As many as 109 deaths have been reported across the country due to the deadly disease.
There are 3666 active cases in the country while 292 people have been cured/discharged/migrated.

Maharashtra has reported the highest number of COVID-19 cases so far, standing at 690, followed by Tamil Nadu and Delhi with 571 and 503 cases respectively. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.